These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28938547)

  • 41. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small nucleolar RNA 47 promotes tumorigenesis by regulating EMT markers in hepatocellular carcinoma.
    Li G; He Y; Liu X; Zheng Z; Zhang M; Qin F; Lan X
    Minerva Med; 2017 Oct; 108(5):396-404. PubMed ID: 28466632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulation of RNF187 induces hepatocellular carcinoma cell epithelial to mesenchymal transitions.
    Yu SL; Wu JC; Liu PF; Liu K; Ye C; Zhou KL; Li ZR; Xu YP
    Oncotarget; 2017 Nov; 8(60):101876-101886. PubMed ID: 29254210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.
    Zhang D; Zhou P; Wang W; Wang X; Li J; Sun X; Zhang L
    Oncol Rep; 2016 Jan; 35(1):366-74. PubMed ID: 26499912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma.
    Zhang J; Ren Z; Zheng D; Song Z; Lin J; Luo Y; Zou X; Pan Y; Qi N; Li A; Liu X
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition.
    Zhang T; Guo J; Gu J; Chen K; Wang Z; Li H; Wang G; Wang J
    J Cancer; 2019; 10(15):3501-3516. PubMed ID: 31293655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma.
    Li S; Li J; Yu Z
    Onco Targets Ther; 2019; 12():5537-5544. PubMed ID: 31371991
    [No Abstract]   [Full Text] [Related]  

  • 48. PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma
    Han X; Zhu Y; Shen L; Zhou Y; Pang L; Zhou W; Gu H; Han K; Yang Y; Jiang C; Xie J; Zhang C; Ding L
    Front Oncol; 2021; 11():629916. PubMed ID: 33833989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcription co-activator P300 activates Elk1-aPKC-ι signaling mediated epithelial-to-mesenchymal transition and malignancy in hepatocellular carcinoma.
    Ma C; Huang S; Xu L; Tian L; Yang Y; Wang J
    Oncogenesis; 2020 Mar; 9(3):32. PubMed ID: 32144235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.
    Li H; Luo D; Huttad L; Zhang M; Wang Y; Feng J; Ding Y; Han B
    Front Mol Biosci; 2021; 8():654766. PubMed ID: 34222329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis.
    Zhang Y; Luo X; Lin J; Fu S; Feng P; Su H; He X; Liang X; Liu K; Deng W
    J Oncol; 2020; 2020():1980368. PubMed ID: 32377190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ARL8B promotes hepatocellular carcinoma progression and inhibits antitumor activity of lenvatinib via MAPK/ERK signaling by interacting with RAB2A.
    Cao MM; Li YM; Ding X; Fang F; Yang LY
    Cell Signal; 2024 Dec; 124():111470. PubMed ID: 39413890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FAM21C Promotes Hepatocellular Carcinoma Invasion and Metastasis by Driving Actin Cytoskeleton Remodeling
    Lu Y; Huang D; Wang B; Zheng B; Liu J; Song J; Zheng S
    Front Oncol; 2021; 11():809195. PubMed ID: 35096613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolated right ventricular metastasis of hepatocellular carcinoma induced by epithelial-mesenchymal transition: a case report.
    Saku K; Tahara N; Fukumoto Y; Tanaka H
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa517. PubMed ID: 33598612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism.
    Ng KT; Yeung OW; Lam YF; Liu J; Liu H; Pang L; Yang XX; Zhu J; Zhang W; Lau MYH; Qiu WQ; Shiu HC; Lai MK; Lo CM; Man K
    Cell Death Discov; 2021 Jul; 7(1):188. PubMed ID: 34290233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31.
    Chen X; Ye Q; Zhao W; Chi X; Xie C; Wang X
    Cell Death Discov; 2022 Jul; 8(1):334. PubMed ID: 35869046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma.
    Zhang T; Huang Y; Liu W; Meng W; Zhao H; Yang Q; Gu SJ; Xiao CC; Jia CC; Zhang B; Zou Y; Li HP; Fu BS
    Oncogenesis; 2017 Jul; 6(7):e363. PubMed ID: 28737756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.
    Lei X; Liang Y; Chen J; Xiao S; Lei J; Li J; Duanmu J; Jiang Q; Liu D; Tang C; Li T
    Sci Rep; 2018 Aug; 8(1):11857. PubMed ID: 30072770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corrigendum to High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial-mesenchymal transition: International Journal of Infectious Diseases [20 (2014)] 37-41.
    Wang T; Jin Y; Zhao R; Wu Y; Zhang Y; Wu D; Kong D; Jin X; Zhang F
    Int J Infect Dis; 2016 Jan; 42():50. PubMed ID: 28991537
    [No Abstract]   [Full Text] [Related]  

  • 60. LLGL2 Increases Ca
    Leng S; Xie F; Liu J; Shen J; Quan G; Wen T
    Front Oncol; 2021; 11():683629. PubMed ID: 34178676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.